Chronic migraine develops when episodic migraines gradually worsen over time, driven by changes in how the brain processes pain signals. The diagnosis applies when you have headaches on 15 or more days per month for longer than three months, with at least 8 of those days meeting the criteria for migraine. Understanding what fuels this transition from occasional attacks to a near-constant condition involves genetics, brain chemistry, hormones, and sometimes the very medications used to treat the pain.
How the Brain Generates a Migraine Attack
Every migraine starts with abnormal activation of a pain-signaling network that connects the brain’s surface to deep processing centers. Nerve fibers surrounding the blood vessels in the brain’s outer membranes become activated, releasing a signaling molecule called CGRP (calcitonin gene-related peptide). CGRP triggers a cascade: blood vessels dilate, immune cells called mast cells release inflammatory compounds, and the surrounding nerve endings become hypersensitive. This is sometimes called neurogenic inflammation, and it’s the engine behind migraine pain.
Pain signals travel from these nerve endings into the brainstem and upper spinal cord, where they’re relayed to the thalamus, a structure that acts as the brain’s sensory switchboard. From there, the signals fan out to regions responsible for processing touch, sound, vision, and even smell. That widespread distribution explains why migraines aren’t just headaches. They affect your ability to tolerate light, noise, and physical movement all at once.
Many attacks also involve a phenomenon called cortical spreading depression: a slow wave of intense nerve cell activity that rolls across the brain’s surface at about 2 to 6 millimeters per minute, followed by 15 to 30 minutes of suppressed activity. This wave is what produces the visual disturbances, tingling, or speech difficulties some people experience as aura. It also sensitizes the pain-signaling nerves on the brain’s surface, feeding more input into the cycle.
Why Episodic Migraines Become Chronic
The shift from occasional migraines to chronic ones is called chronification, and it hinges on a process known as central sensitization. Each time the pain-signaling network fires during a migraine, it leaves the system slightly more excitable than before. Over time, neurons in the brainstem that relay pain signals start responding more intensely to normal input, amplifying pain that wouldn’t have registered before. Think of it like a volume knob that gets turned up a little with every attack and never fully returns to its original setting.
CGRP plays a central role in this escalation. Released by small nerve fibers in the trigeminal ganglion (the nerve cluster behind your eye), it binds to receptors on neighboring nerve cells and supporting glial cells, promoting a feedback loop that sustains inflammation and pushes the system toward chronic sensitivity. Repeated activation of the brain’s built-in pain-modulation pathways, particularly a region called the periaqueductal gray, also contributes to progression. This area normally helps dampen pain signals, but chronic overstimulation can impair its function.
One measurable sign of central sensitization is cutaneous allodynia, where ordinary touch on the skin becomes painful during or between attacks. About 63% of people with migraine experience this, and the more frequent your headaches, the more likely you are to have it in a severe form. Among people with headaches on 104 to 179 days per year, roughly 26% have severe skin sensitivity, compared to about 13% of those with fewer than 6 headache days per year. Severe allodynia is also tied to higher levels of disability: 35% of people with severe migraine-related disability have it, versus about 14% of those with no disability. If brushing your hair or resting your head on a pillow hurts during a migraine, that’s allodynia, and it signals that your nervous system is becoming increasingly sensitized.
Genetic Susceptibility
Migraine has a strong inherited component. A large genome-wide study of over 102,000 migraine cases identified 123 genetic risk locations, many of which affect how nerve cells communicate and how blood vessels function. Some of these genetic variants are specific to migraine with aura, including one near a gene (CACNA1A) that controls calcium channels in nerve cells, directly influencing how easily those cells fire. Other variants are specific to migraine without aura.
Notably, the study found risk variants in the genes that produce CGRP itself (CALCA and CALCB), reinforcing just how central this molecule is to migraine biology. Variants near the gene for the serotonin 1F receptor also appeared, which is significant because this receptor is the target of an existing class of migraine medications. If your parents or siblings have migraine, your genetic makeup likely includes some combination of these risk variants, lowering the threshold at which your brain tips into an attack.
Hormonal Triggers
Estrogen fluctuations are one of the most potent and well-documented migraine triggers, which is why chronic migraine is roughly twice as common in women as in men. The trigger isn’t high estrogen or low estrogen per se. It’s the withdrawal, the rapid drop that occurs in the days before menstruation, during the placebo week of oral contraceptives, or in the transition to menopause.
Falling estrogen levels promote cortical spreading depression, making the brain more susceptible to the wave of nerve activation that kicks off an attack. This hormonal sensitivity means that women often notice their migraines clustering around their periods, worsening during perimenopause when estrogen levels become erratic, and sometimes improving after menopause when hormone levels stabilize at a consistently low baseline.
Medication Overuse: A Hidden Driver
One of the most common and preventable causes of chronic migraine is the overuse of the very drugs meant to stop attacks. When you take acute migraine medications too frequently, the brain adapts to their presence, and headaches begin rebounding between doses. The thresholds are lower than many people realize: using triptans, opioids, or combination painkillers on 10 or more days per month for three months can trigger medication overuse headache. For over-the-counter options like ibuprofen or acetaminophen, the threshold is 15 days per month.
This creates a vicious cycle. More headache days lead to more medication use, which leads to still more headache days. Many people who meet the criteria for chronic migraine are unknowingly caught in this loop. Reducing or withdrawing from the overused medication is often a necessary first step before any preventive strategy can work, though the withdrawal period itself typically involves a temporary worsening of headaches.
Sleep Disorders and Other Compounding Factors
Chronic migraine rarely exists in isolation. Sleep apnea has a particularly strong association: about 37% of all migraine patients score as high-risk for sleep apnea, and that number jumps to nearly 52% among those with chronic migraine. Research using genetic analysis methods has confirmed a likely causal link between obstructive sleep apnea and migraine with aura, not just a coincidental overlap. Poor sleep quality fragments the brain’s restorative processes and lowers the threshold for migraine activation, so untreated sleep apnea can be a hidden engine keeping migraines chronic.
Obesity, depression, anxiety, and high caffeine intake are also consistently linked to the progression from episodic to chronic migraine. These aren’t just lifestyle factors that happen to co-occur. They share overlapping neurological pathways with migraine and can independently increase nervous system excitability, sustain inflammation, or disrupt the brain’s pain-modulation circuits.
How Prevention Targets These Causes
Because CGRP is so central to both individual attacks and the chronification process, therapies that block this molecule have become a first-line preventive option for chronic migraine. These treatments, available as monthly or quarterly injections and as daily oral pills, work by either neutralizing CGRP directly or blocking the receptors it binds to. For many people with chronic migraine, they reduce monthly headache days significantly, and they don’t carry the risk of medication overuse headache since they aren’t taken as-needed for acute pain.
Older preventive categories, including certain blood pressure medications, antiseizure drugs, and specific antidepressants, remain effective options as well. The choice often depends on what other conditions you’re managing. If you have co-existing high blood pressure, a beta-blocker might address both. If sleep is a major issue, a sedating antidepressant taken at night could serve double duty. The goal of any preventive approach is to reduce the frequency of attacks enough to let the sensitized nervous system calm down and, ideally, reverse some of the chronification process.
Addressing modifiable risk factors matters just as much as medication. Screening for and treating sleep apnea, tapering overused acute medications, stabilizing sleep schedules, and managing weight and mood disorders can each independently reduce headache frequency. For many people, chronic migraine results from several of these factors stacking on top of a genetic predisposition, and pulling even one or two out of the equation can shift the balance back toward episodic migraine.